Homocysteine to hydrogen sulfide or hypertension. - Wikidata - awgldk - TriplyDB

Homocysteine to hydrogen sulfide or hypertension.

Homocysteine to hydrogen sulfide or hypertension.

http://www.wikidata.org/entity/Q34066620

about

Role of cystathionine γ-lyase/hydrogen sulfide pathway in cardiovascular disease: a novel therapeutic strategy?The methionine sulfoxide reduction system: selenium utilization and methionine sulfoxide reductase enzymes and their functions Hydrogen Sulfide as a Potential Therapeutic Target in Fibrosis Glutathione redox control of asthma: from molecular mechanisms to therapeutic opportunities Plasma homocysteine is associated with aortic arterial stiffness but not wave reflection in Chinese hypertensive subjects H2S-releasing nanoemulsions: a new formulation to inhibit tumor cells proliferation and improve tissue repair.The Prevalence of Hypertension Accompanied by High Homocysteine and its Risk Factors in a Rural Population: A Cross-Sectional Study from Northeast China.Hydrogen sulfide deactivates common nitrobenzofurazan-based fluorescent thiol labeling reagents.H2S and homocysteine control a novel feedback regulation of cystathionine beta synthase and cystathionine gamma lyase in cardiomyocytes.Ablation of MMP9 gene ameliorates paracellular permeability and fibrinogen-amyloid beta complex formation during hyperhomocysteinemia.Cystathionine β-synthase and cystathionine γ-lyase double gene transfer ameliorate homocysteine-mediated mesangial inflammation through hydrogen sulfide generation Hyperhomocysteinemia associates with small vessel disease more closely than large vessel disease.Folic acid supplementation attenuates hyperhomocysteinemia-induced preeclampsia-like symptoms in rats.Hydrogen sulfide mitigates homocysteine-mediated pathological remodeling by inducing miR-133a in cardiomyocytes Remodeling in vein expresses arterial phenotype in hyperhomocysteinemia.A practical look at the chemistry and biology of hydrogen sulfide.Increased endogenous H2S generation by CBS, CSE, and 3MST gene therapy improves ex vivo renovascular relaxation in hyperhomocysteinemia.Top Three Pharmacogenomics and Personalized Medicine Applications at the Nexus of Renal Pathophysiology and Cardiovascular Medicine.Emerging role of hydrogen sulfide in hypertension and related cardiovascular diseases Effect of losartan with folic acid on plasma homocysteine and vascular ultrastructural changes in spontaneously hypertensive rats Thiol reactive probes and chemosensors.Protective role of methionine sulfoxide reductase A against ischemia/reperfusion injury in mouse kidney and its involvement in the regulation of trans-sulfuration pathway H-Type Hypertension and C Reactive Protein in Recurrence of Ischemic Stroke.The therapeutic potential of hydrogen sulfide: separating hype from hope.Emerging role of hydrogen sulfide in health and disease: critical appraisal of biomarkers and pharmacological tools.Hydrogen sulfide and renal ischemia.Hydrogen sulfide in the pathogenesis of atherosclerosis and its therapeutic potential.Updating the relationship between hyperhomocysteinemia lowering therapy and cardiovascular events.Endothelial dysfunction: the link between homocysteine and hydrogen sulfide.Atherogenesis: hyperhomocysteinemia interactions with LDL, macrophage function, paraoxonase 1, and exercise.Homocysteine and hydrogen sulfide in epigenetic, metabolic and microbiota related renovascular hypertension.Functional and Molecular Insights of Hydrogen Sulfide Signaling and Protein Sulfhydration.A Meta-Analysis of Folic Acid in Combination with Anti-Hypertension Drugs in Patients with Hypertension and Hyperhomocysteinemia.Association between homocysteine and incidence of ischemic stroke in subjects with essential hypertension: a matched case-control study.Sodium hydrosulfide attenuates hyperhomocysteinemia rat myocardial injury through cardiac mitochondrial protection.The differential diagnostic value of serum homocysteine for white coat hypertension.Physical Exercise Is a Potential "Medicine" for Atherosclerosis.Folic Acid and Homocysteine in Chronic Kidney Disease and Cardiovascular Disease Progression: Which Comes First?Design of a Novel Composite H2 S-Releasing Hydrogel for Cardiac Tissue Repair.Analysis of plasminogen activator inhibitor-1, integrin beta3, beta fibrinogen, and methylenetetrahydrofolate reductase polymorphisms in Iranian women with recurrent pregnancy loss.

P2860

Q26827551-C2377391-E446-4B71-9694-7C42C812321F Q26864476-CF3AF1F4-A6A6-494C-8E07-474D44BEBF93 Q27011111-270B0746-AD58-4B1F-BF94-694269C4CC17 Q27694579-57C0E881-95A4-439A-807D-A954CF30CD51 Q28539176-DCFD5F6A-42FC-44BA-BFC8-3952007B9A6E Q30358087-B6D54595-203F-460A-8DF6-E6FE17A5D85E Q33616058-8E56B2B6-5038-4CBA-8A7D-39C5DB059CEA Q33777172-136FA0C6-A17D-41A1-AA5F-12F38210DA6D Q33808178-32110840-1ADD-480A-881A-635F934B5307 Q34153400-D1BE2799-3A3E-47DA-9537-A59552E562D4 Q34501679-507695C8-A37A-472D-8C1D-D097D2E23C78 Q34649100-7DA665FF-70E8-4D93-AFC2-AD093D2EFD37 Q34984367-E2635B92-863C-40D0-BC0E-2DED315D762C Q35561647-1EF032B7-A607-4CB8-B547-AE9E662A63DF Q35591408-E0DF46C4-2D3A-4763-8CF5-9D2EC3F42C6F Q35929034-26E7A158-801D-4D1C-8566-8E07DB343B9A Q36114692-074DF184-09D1-4A80-B9AD-873C90DA9D8D Q36285918-FC80330C-F8F2-4FFD-BDCD-4FE2782453CA Q36342111-F393953E-C436-4525-8215-E4B2C9BF1927 Q36375258-CF7F518E-433E-449A-8049-9C9AB3C6E018 Q36468604-FDB99DA5-5148-44BA-B26D-757674E2E703 Q36801517-13081377-963E-424C-9868-36C42D36DB78 Q36937923-580C2E50-7578-40D6-8BD6-89C0822EDAD3 Q37872122-4031ED9C-A6BF-4F1F-93E0-0D1F2B3E7F9C Q37917815-EF95B65F-1825-45D7-8FFC-1943337C67B6 Q37960612-3D67C4A2-7946-4786-AD84-558C37208048 Q37960617-2140B474-CBC6-449A-8CF5-9E7D1DD8B9EA Q38053468-EAE2FFCD-A76E-408F-96C5-EE6C4B96570A Q38227415-F301FE62-D62B-4D03-8326-C95BCF7E7BC3 Q38724228-EE600194-85F1-45D7-A78D-CB0F45697B16 Q38948319-59BBEA75-511A-4F5E-81E9-D3CF00753465 Q39053014-631464E7-CEBB-424D-B268-513BCD5AE11E Q41611205-B4900189-BFDB-4761-8300-97A31469929A Q41727294-BD5902FB-30D0-4B61-8A87-147202509ADB Q46817216-F3E6448A-53CD-4A45-A868-A9E770C5359A Q47103738-0AB9849E-6B6A-4E70-9078-C2F97C0B2C42 Q50096397-977316D3-C62C-4927-90C6-0248311C1A25 Q50102454-79870B59-E2E2-4312-817A-D2AFAFE229D2 Q51531585-6644A073-04AD-454A-BE15-97131FFA28FF Q54392340-2C033840-45F5-45F6-9AB7-994E3C35D543

P2860

Homocysteine to hydrogen sulfide or hypertension.

http://www.wikidata.org/entity/Q34066620

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Homocysteine to hydrogen sulfide or hypertension.

@ast

Homocysteine to hydrogen sulfide or hypertension.

@en

Homocysteine to hydrogen sulfide or hypertension.

@nl

type

label

Homocysteine to hydrogen sulfide or hypertension.

@ast

Homocysteine to hydrogen sulfide or hypertension.

@en

Homocysteine to hydrogen sulfide or hypertension.

@nl

prefLabel

Homocysteine to hydrogen sulfide or hypertension.

@ast

Homocysteine to hydrogen sulfide or hypertension.

@en

Homocysteine to hydrogen sulfide or hypertension.

@nl

P1433

Q34066620-E504900F-C4BF-4A63-B0F1-1ACF7A695E30

P1476

Q34066620-F371C388-D879-4758-9FE9-7DB66CA7A5E1

P2093

Q34066620-18E280A1-751F-4003-9E2E-804BA97249DB

Q34066620-221EBD61-5623-468B-A8D3-ABB450E2CBA3

Q34066620-3294E203-0885-4788-9C47-FF90A606B434

Q34066620-8B280740-8F6B-4AD2-B7D6-9E4834177142

P2860

Q34066620-04BFF36A-39B4-4240-A911-963243A5FC0F

Q34066620-068D11F4-9791-4272-A8CE-CB4A8642C406

Q34066620-0840D758-992E-4672-A75D-A634149A3C23

Q34066620-0E325F9A-472E-4C86-8703-5500BA107C28

Q34066620-0FC39BC1-B75E-4BE1-8772-8595201DFCA4

Q34066620-1A319EF4-6E8B-491B-B32B-177C729E8ED6

Q34066620-3B9B9604-7CDA-4814-9C8B-D6641EB9A32E

Q34066620-3F897017-1FF6-49DC-9C16-7AC4539C3173

Q34066620-4420098D-C84F-4524-811F-2A76D7FCB6B8

Q34066620-44773F3B-5C21-4DCE-95C3-272E63396089

P2888

Q34066620-2D19673D-1EE7-4F96-BDFB-876B1E862F2F

P304

Q34066620-597D68A4-3252-46D1-8E77-B556EC51A73D

P31

Q34066620-0A9D66B9-EB7F-4088-9061-A64EEBACE846

P356

Q34066620-BA25EF7F-F32A-487A-91D4-185FF49E5681

P433

Q34066620-9EA4D692-FA65-47EF-8EC1-6254A9714D68

P478

Q34066620-690D618E-355A-4BB3-8085-5429ABA836F4

P577

Q34066620-744F970B-23C5-4E41-AD8B-32CED95C99DD

P5875

Q34066620-6307798F-605A-4568-8A31-073ED4A80E74

P6179

Q34066620-26E65587-BA1E-43DC-A459-7746863F496D

P698

Q34066620-E3BBDFE7-D210-4F1D-A3D2-DD8C4B360D56

P932

Q34066620-7F000223-72D9-4171-85D8-DD81AC5B9717

P356

S12013-010-9079-Y

P1433

Cell Biochemistry and Biophysics

P1476

Homocysteine to hydrogen sulfide or hypertension.

@en

P2093

Neetu Tyagi

http://www.w3.org/2001/XMLSchema#string

Paras K Mishra

http://www.w3.org/2001/XMLSchema#string

Suresh C Tyagi

http://www.w3.org/2001/XMLSchema#string

Utpal Sen

http://www.w3.org/2001/XMLSchema#string

P2860

Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine

Relative contributions of cystathionine beta-synthase and gamma-cystathionase to H2S biogenesis via alternative trans-sulfuration reactions.

H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase

A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group

The vasorelaxant effect of H(2)S as a novel endogenous gaseous K(ATP) channel opener

Protein homocysteinylation: possible mechanism underlying pathological consequences of elevated homocysteine levels

Induction of cyclin A gene expression by homocysteine in vascular smooth muscle cells

3-Mercaptopyruvate sulfurtransferase produces hydrogen sulfide and bound sulfane sulfur in the brain

Cystathionine gamma-lyase overexpression inhibits cell proliferation via a H2S-dependent modulation of ERK1/2 phosphorylation and p21Cip/WAK-1

The pathogenesis of atherosclerosis: a perspective for the 1990s

P2888

s12013-010-9079-y

P304

49-58

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12013-010-9079-Y

http://www.w3.org/2001/XMLSchema#string

P433

2-3

http://www.w3.org/2001/XMLSchema#string

P478

57

http://www.w3.org/2001/XMLSchema#string

P577

2010-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

43132096

http://www.w3.org/2001/XMLSchema#string

P6179

1010785578

http://www.w3.org/2001/XMLSchema#string

P698

20387006

http://www.w3.org/2001/XMLSchema#string

P932

2921842

http://www.w3.org/2001/XMLSchema#string